🔗 Visit the ClinicalTrials.gov page for NCT01505634
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. | Clin Infect Dis | 2013 | 4.07 |
| 2 | New β-lactamase inhibitors: a therapeutic renaissance in an MDR world. | Antimicrob Agents Chemother | 2013 | 1.47 |
| 3 | New β-Lactamase Inhibitors in the Clinic. | Infect Dis Clin North Am | 2016 | 0.89 |
| 4 | Beyond Susceptible and Resistant, Part III: Treatment of Infections due to Gram-Negative Organisms Producing Carbapenemases. | J Pediatr Pharmacol Ther | 2016 | 0.75 |
| 5 | Pipeline of Known Chemical Classes of Antibiotics. | Antibiotics (Basel) | 2013 | 0.75 |